The key difference between medical cannabis compliance testing and R&D testing at ACS Laboratory is that compliance testing measures potency and detects contaminants as mandated by the Florida Department of Health. In contrast, R&D testing is a voluntary process designed to enhance product development by providing deeper insights into cannabinoid profiles, terpene content, and formulation features.

This article explains the key differences between compliance testing and R&D testing for medical cannabis in Florida, why medical marijuana treatment centers (MMTCs) benefit from these tests, and how ACS Laboratory ensures quality and safety.  

‍

What Is Medical Cannabis Compliance Testing?

Medical cannabis compliance testing is a mandatory process required by Florida law to ensure patient safety and regulatory compliance. The Florida Department of Health’s Office of Medical Marijuana Use (OMMU), which regulates medical marijuana sales and distribution between patients and physicians, states that:

• “All low-THC cannabis, medical marijuana, derivative products, and edibles must be tested within the state of Florida.”
• Regulatory cannabis testing in Florida entails strict regulations that require all Medical Marijuana Treatment Centers (MMTCs) to work with Florida-certified marijuana testing laboratories (CMTLs).

‍

Florida MMTC testing requirements

The primary objectives of compliance testing aim to ensure that medical cannabis products are high-quality and safe, specifically:

• The labeling of THC and CBD concentrations is accurate.
• Medical cannabis is free from contaminants that are unsafe for human consumption.

‍

Accurate THC labeling: Cannabinoid potency testing verifies products contain the amount of THC listed on the label. This test analyzes the concentration of cannabinoids, precisely measuring the total amount of Delta-9 THC and CBD.

‍

Contaminant screening: Medical cannabis products must not exceed the Florida Department of Health’s acceptable limits on potential contaminants. Quality-control tests for safety analyze medical cannabis for:

• Microbes, like bacteria and fungi
• Mycotoxins, or secondary metabolites produced by fungi
• Agricultural agents, such as pesticides
• Residual solvents, which manufacturers use to extract cannabinoids for concentrated products
• Heavy metals that can seep into cultivated crops
• Other filth and foreign materials 

‍

Medical cannabis compliance testing is essential for consumer safety. Florida law requires MMTCs to prove all products have passed quality-control tests before they enter the market. MMTCs working with approved third-party laboratories have peace of mind that their products are compliant with state law, meaning they won’t be denied market access or face costly recalls. 

‍

What Is Medical Cannabis R&D Testing?

Medical cannabis R&D testing is a process designed to enhance product development by providing deeper insights into cannabinoid profiles, terpene content, and formulation features. Typically, R&D testing occurs before compliance testing or when MMTCs are considering working with new formulas or suppliers. 

• R&D testing allows brands to refine formulations, improve product quality, and optimize ingredients. 
• MMTCs do not have to report R&D testing results to the OMMU.

‍

How R&D testing helps MMTCs

A la carte R&D cannabis tests gather critical insights during product development. Some essential benefits of R&D testing for medical cannabis include:

• Optimizing cannabinoid and terpene profiles helps brands design products for specific medical conditions and patient needs.
• Identifying contaminants early in the cultivation or processing stages reduces money and time spent on poor-quality batches. 
• Testing experimental formulations for edibles, tinctures, and other product types helps fine-tune their quality and potency. 

‍

Key Differences Between Compliance and R&D Testing 

Medical cannabis compliance and R&D testing are both integral to ensuring MMTCs and patients receive high-quality products that deliver their intended effects. However, there are key differences between why MMTCs conduct these tests, the test types, and when they occur. 

Here is an overview of compliance testing vs. R&D testing:

‍

Medical Cannabis Compliance Testing

Purpose

Mandatory testing to prove products are labeled accurately and safe to consume

Requirements

• MMTCs must report test results to OMMU 
• MMTCs must work with Florida-certified marijuana testing laboratories (CMTLs) to conduct compliance testing

Test Types

• Potency testing measures cannabinoid content, specifically THC and CBD concentrations
• Contaminant testing looks for harmful compounds listed by the Florida Department of Health

Timeline

After processing, before being sold to patients

‍

R&D Testing

Purpose

Voluntary testing to improve medical cannabis products

Requirements

• Optional
• Results do not need to be reported to OMMU

Test Types

• Terpene profiling
• Cannabinoid profiling
• Shelf life and stability testing
• Pre-harvest and planting tests

Timeline

Typically before final processing and compliance testing

‍

Meeting Florida’s MMTC Regulatory Testing Requirements with ACS Laboratory

ACS Laboratory medical cannabis testing provides MMTCs with reliable, comprehensive results they can trust to meet stringent OMMU guidelines. In addition, ACS Laboratory works with medical marijuana treatment centers on the sample-submission process to mitigate potential confusion with regulations and improper handling that can lead to compliance failures. 

ACS compliance panels

Using medical-grade equipment and expert testing methods, ACS Laboratory’s compliance testing panels encompass the following Florida Department of Health requirements for MMTCs:

‍

• Cannabinoid Potency: ACS laboratory tests MMTC cannabis for 11 cannabinoids per OMMU requirements. 
• Pesticide Testing: Compliance testing at ACS Laboratory includes Florida’s 67 mandated pesticides, including several fungicides, herbicides, and plant growth regulators.
• Mycotoxins Testing: ACS Laboratory includes 5 mycotoxins required by Florida law.
• Pathogenic Microbiology: ACS Laboratory’s Florida MMTC compliance panel screens cannabis for 7 pathogenic compounds known to cause illness in humans, including Salmonella, Aspergillus, yeast, and mold.
• Heavy Metals Testing: ACS Laboratory’s medical cannabis testing panels analyze plants, extracts, and edibles for 4 heavy metals referred to as the “big four”—Arsenic (As), Cadmium (Cd), Lead (Pb), and Mercury (Hg). 
• Water Activity: Florida compliance panels at ACS test all cannabis products for water activity per state safety standards. 
• Moisture Levels: Florida law requires testing cannabis plants and flower for moisture levels to prevent potential mold growth.
• Residual Solvents Testing: Per Florida’s OMMU rules, ACS screens cannabis derivatives and edibles for 21 residual solvents.
• Homogeneity Testing: Florida law requires that edibles undergo homogeneity tests to ensure they contain a consistent amount of THC throughout.
• Filth and Foreign Material: Florida law requires that cannabis products undergo filth and foreign material testing to ensure that no more than 10% of the product's surface area is contaminated with filth and debris and that feces contamination does not exceed 0.5%.

‍

Additional benefits for MMTCs

ACS Laboratory’s expert medical cannabis staff is available to assist MMTCs in addressing numerous issues related to compliance, such as:

• How to submit samples and navigate complicated Florida regulations
• Contamination mitigation and remediation services for products that don’t meet Florida standards
• Root-cause analysis services, such as identifying the source of an internal contamination issue
• Advising on the approved forms of cannabis production
• Developing best practices for production, record-keeping, and sampling

‍

ACS Laboratory goes above and beyond to ensure that the results detailed in every certificate of analysis (COA) are verified and legally defensible. This dedication helps MMTCs stay ahead of the curve and mitigate failed tests that can lead to product recalls or license suspensions. 

‍

R&D Testing with ACS Laboratory

ACS Laboratory offers numerous a la carte R&D testing options that can help MMTCs enhance product quality and market products better to consumers. Some of the most popular R&D testing for medical cannabis include:

‍

Terpene Profiling: Terpenes are the essential oils in cannabis that help modulate the plant’s medicinal properties and contribute to its overall effects. ACS Laboratory can test for 38 terpenes in medical cannabis products, giving MMTCs valuable insight into how products benefit patients.  

‍

Flavonoid Testing: Flavonoids impact the pigmentation, aroma, and overall characteristics of cannabis plants. ACS can test for 16 flavonoids in medical cannabis, which are also considered synergistic with cannabinoids and terpenes to produce the plant’s overall therapeutic effect.

‍

Shelf-Life Testing: Most perishable products in the United States undergo analytical testing to determine their life expectancy (“shelf life”) under normal storage conditions before excessive deterioration occurs. ACS offers shelf-life and stability tests that can help determine optimal packaging and storage conditions for medical cannabis products and ensure a consistent consumer experience.

‍

Pre-Harvest Testing: Even before planting, ACS can test seedlings for THC potency and the presence of 32 other cannabinoids, including CBD, CBG, and CBT. Seedling potency tests can verify whether the seed’s genetics are performing as planned. ACS can also perform a growth potential analysis, identifying issues that could impact a healthy harvest, such as nutrient levels in the soil.

‍

Conclusion

Medical cannabis compliance testing is mandatory and checks for cannabinoid potency and contaminants. MMTCs must show compliance test results before they can sell products to patients. R&D testing for medical cannabis, on the other hand, is optional and can help MMTCs optimize product development and identify potential issues before planting and harvest. 

ACS Laboratory proudly serves MMTCs across Florida by ensuring patients receive safe, thoroughly tested products. By incorporating R&D testing, ACS can help MMTCs drive innovation in the medical cannabis industry, enhancing product quality and effectiveness. Partnering with ACS means MMTCs can mitigate the risk of product recalls while meeting the highest safety and quality standards.= 

‍

Looking for reliable medical cannabis testing in Florida? Partner with ACS Laboratory for expert compliance and R&D testing services tailored to MMTCs. Learn more here.